Literature DB >> 33552974

circ_NOTCH3 Functions as a Protooncogene Competing With miR-205-5p, Modulating KLF12 Expression and Promoting the Development and Progression of Basal-Like Breast Carcinoma.

Bing Guan1, Qing Li2, Hui-Zhen Zhang3, Hai-Sheng Yang1.   

Abstract

Breast cancer is the most common type of cancer diagnosed among women, and basal-like breast carcinoma (BLBC) has been associated with a more aggressive histology, poorer prognosis, and non-responsiveness to hormone therapy. In the present study, the role and molecular mechanism of circular (circ)_NOTCH3 in the development and progression for BLBC was identified. circ_RNAs array was used to screen the ectopic expression of hsa_circ_0109177 (circ_NOTCH3) in BLBC. RT-qPCR was conducted to evaluate the circ_NOTCH3 expression in BLBC tissues and paired normal tissues, as well as related cell lines. Cell function changes were analyzed following circ_NOTCH3 or micro (mi)RNA overexpression or co-expression. Bioinformatics analysis and dual-luciferase reporter assay were performed to predict and verify the binding sites between circ_NOTCH3 and miRNAs. Gene expression changes were assessed using western blotting. circ_NOTCH3 had a significantly higher expression in BLBC tissues and cell lines. The upregulation of circ_NOTCH3 promoted the proliferation, migration, invasion and inhibited the apoptosis for BLBC cells. The opposite results were observed following miR-205-5p overexpression. However, the co-expression of circ_NOTCH3 and miR-205-5p resulted in those restoration. circ_NOTCH3 is capable of binding to miR-205-5p, and upregulating its target gene KLF12, which can be downregulated by miR-205-5p overexpression and restored by the co-expression of circ_NOTCH3 and miR205-5p. circ_NOTCH3, being an protooncogene and a powerful biomarker, can function as a sponge, compete with miR-205-5p, modulate KLF12 expression, and promote the development and progression of BLBC.
Copyright © 2021 Guan, Li, Zhang and Yang.

Entities:  

Keywords:  KLF12; basal-like breast carcinoma; biomarker; circ_NOTCH3; circ_RNA; miR-205-5p; progression; protooncogene

Year:  2021        PMID: 33552974      PMCID: PMC7857013          DOI: 10.3389/fonc.2020.602694

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  49 in total

1.  MicroRNA-205 directly targets Krüppel-like factor 12 and is involved in invasion and apoptosis in basal-like breast carcinoma.

Authors:  Bing Guan; Qing Li; Li Shen; Qiu Rao; Yan Wang; Yun Zhu; Xiao-Jun Zhou; Xiao-Hong Li
Journal:  Int J Oncol       Date:  2016-06-08       Impact factor: 5.650

2.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.

Authors:  Yan Li; Qiupeng Zheng; Chunyang Bao; Shuyi Li; Weijie Guo; Jiang Zhao; Di Chen; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Cell Res       Date:  2015-07-03       Impact factor: 25.617

3.  The hepatitis delta (delta) virus possesses a circular RNA.

Authors:  A Kos; R Dijkema; A C Arnberg; P H van der Meide; H Schellekens
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

4.  Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer.

Authors:  Shuangyan Tan; Qiheng Gou; Wenchen Pu; Chenglin Guo; Yun Yang; Ke Wu; Yaxin Liu; Lunxu Liu; Yu-Quan Wei; Yong Peng
Journal:  Cell Res       Date:  2018-04-08       Impact factor: 25.617

5.  Prognostic markers in triple-negative breast cancer.

Authors:  Emad A Rakha; Maysa E El-Sayed; Andrew R Green; Andrew H S Lee; John F Robertson; Ian O Ellis
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

6.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

7.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

8.  Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.

Authors:  Hongliang Zang; Yuhui Li; Xue Zhang; Guomin Huang
Journal:  Thorac Cancer       Date:  2020-05-23       Impact factor: 3.500

9.  Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway.

Authors:  Zhi-Hong Zong; Yao Liu; Shuo Chen; Yang Zhao
Journal:  J Cell Mol Med       Date:  2020-02-19       Impact factor: 5.310

10.  Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis.

Authors:  Weiping Yang; Piguo Gong; Yifeng Yang; Chunyan Yang; Baohui Yang; Lijun Ren
Journal:  Cancer Manag Res       Date:  2020-03-27       Impact factor: 3.989

View more
  4 in total

1.  Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma.

Authors:  Lei Bao; Min Wang; Qiqi Fan
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p.

Authors:  Hui Chen; Chen Wu; Liang Luo; Yuan Wang; Fangxing Peng
Journal:  Open Med (Wars)       Date:  2021-09-24

3.  circUSP34 accelerates osteosarcoma malignant progression by sponging miR-16-5p.

Authors:  Jingbing Lou; Hongliang Zhang; Jiuhui Xu; Tingting Ren; Yi Huang; Xiaodong Tang; Wei Guo
Journal:  Cancer Sci       Date:  2021-11-22       Impact factor: 6.716

4.  Circ-ACTR2 aggravates the high glucose-induced cell dysfunction of human renal mesangial cells through mediating the miR-205-5p/HMGA2 axis in diabetic nephropathy.

Authors:  Jie Yun; Jinyu Ren; Yufei Liu; Lijuan Dai; Liqun Song; Xiaopeng Ma; Shan Luo; Yexu Song
Journal:  Diabetol Metab Syndr       Date:  2021-06-26       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.